Deep, specific next-technology sequencing has unveiled that subclonal mutations (i.e., those current in only a portion of tumor cells) may be detected for all driver genes and are connected to swift illness progression and lousy outcome.11–13 This is especially related for TP53This option can be notably precious for non-compliant individuals or T